New patent for Neurocrine drug ONGENTYS April 11, 2024 AutoBot News 0 Annual Drug Patent Expirations for ONGENTYS Ongentys is a drug marketed by Neurocrine and is included in one NDA. It is available from two suppliers. There are nine patents protecting… Source